These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 11593335)

  • 41. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
    Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perspectives for the gene therapy of malignant gliomas by suicide gene transfer.
    Di Meco F; Benedetti S; Colombo MP; Finocchiaro G
    J Neurosurg Sci; 1997 Sep; 41(3):227-34. PubMed ID: 9444575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
    Wildner O; Blaese RM; Candotti F
    Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX; Ngo D; Brade AM; Klamut HJ
    Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
    Touraine RL; Vahanian N; Ramsey WJ; Blaese RM
    Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
    Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
    Haberkorn U; Khazaie K; Morr I; Altmann A; Müller M; van Kaick G
    Nucl Med Biol; 1998 May; 25(4):367-73. PubMed ID: 9639298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
    Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
    Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
    Wildner O; Blaese RM; Morris JC
    Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.
    Huang Q; Pu P; Xia Z; You Y
    J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
    Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y; Zhang X; Hui H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.
    Robe PA; Nguyen-Khac MT; Lambert F; Lechanteur C; Jolois O; Ernst-Gengoux P; Rogister B; Bours V
    Int J Oncol; 2007 Jan; 30(1):283-90. PubMed ID: 17143539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.